Cartaxx
100 mg
V/DCP/25/0075
Alfasan Nederland BV, Nīderlande
QM01AE91
dogs
Vairāk
Medicinal product information
Products
ID
Strength
Package size
Primary packaging
Labelling
V/DCP/25/0075-01
1
PVH/PE/PVDH-Al blisteris, 10 tablete
-
V/DCP/25/0075-02
2
PVH/PE/PVDH-Al blisteris, 10 tablete
-
V/DCP/25/0075-03
3
PVH/PE/PVDH-Al blisteris, 10 tablete
-
V/DCP/25/0075-04
4
PVH/PE/PVDH-Al blisteris, 10 tablete
-
V/DCP/25/0075-05
5
PVH/PE/PVDH-Al blisteris, 10 tablete
-
V/DCP/25/0075-06
6
PVH/PE/PVDH-Al blisteris, 10 tablete
-
V/DCP/25/0075-07
7
PVH/PE/PVDH-Al blisteris, 10 tablete
-
V/DCP/25/0075-08
8
PVH/PE/PVDH-Al blisteris, 10 tablete
-
V/DCP/25/0075-09
9
PVH/PE/PVDH-Al blisteris, 10 tablete
-
V/DCP/25/0075-10
10
PVH/PE/PVDH-Al blisteris, 10 tablete
-
V/DCP/25/0075-11
12
PVH/PE/PVDH-Al blisteris, 10 tablete
-
V/DCP/25/0075-12
25
PVH/PE/PVDH-Al blisteris, 10 tablete
-
Imaverol
100 mg/ml
V/NRP/96/0411
AUDEVARD , Francija
QD01AC90
cattle; horses; dogs
Vairāk
Medicinal product information
Products
ID
Strength
Package size
Primary packaging
Labelling
V/NRP/96/0411-01
100 mg/ml
1
Stikla flakons, 100 ml
[PDF]
[PDF]
[DOCX]
V/NRP/96/0411-02
100 mg/ml
1
Polietilēna flakons, 1000 ml
-
Toxicol vet.
-
V/NRP/03/1611
Zoetis Belgium S.A., Beļģija
QI09AB08
pigs
Vairāk
Medicinal product information
Pharmaceutical form:
suspension for injection
International name (active substance):
E. coli F4ab (K88) antigen,E. coli F4ac (K88 ac) antigen,E. coli F5 (K99) antigen ,E. coli F6 (K987P) antigen,Clostridium perfringens, beta-toxoid (type B and C),Clostridium perfringens, epsilon-toxoid (type D)
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Zoetis Belgium S.A., Beļģija
Date of authorisation/renewal:
08-Dec-2008
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
NRP
Package leaflet:
[PDF] Skat_sadaļā_Zāļu_apraksts (14-Nov-2024)
Labelling text:
[PDF] Skat_sadaļā_Zāļu_apraksts (14-Nov-2024)
Summary of product characteristics:
[DOCX] Zāļu_informācija_ZA_M_LI (14-Nov-2024)
Products
ID
Strength
Package size
Primary packaging
Labelling
V/NRP/03/1611-01
1
Flakons, 50 ml
-
V/NRP/03/1611-02
1
Flakons, 100 ml
-
Poulvac IB Primer
-
V/MRP/21/0037
Zoetis Belgium S.A., Beļģija
QI01AD07
chickens
Medicinal product information
Pharmaceutical form:
Lyophilisate for suspension for spray, eye drop or drinking water administration
International name (active substance):
Live infectious bronchitis virus, strain H120, Live infectious bronchitis virus, strain D274
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Zoetis Manufacturing & Research Spain S.L., Spānija
Date of authorisation/renewal:
28-Jan-2022
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
MRP
Package leaflet:
[PDF] Skat_sadaļā_Zāļu_apraksts (14-Aug-2025)
Labelling text:
[PDF] Skat_sadaļā_Zāļu_apraksts (14-Aug-2025)
Summary of product characteristics:
[DOCX] Zāļu_informācija_ZA_M_LI (14-Aug-2025)
Products
ID
Strength
Package size
Primary packaging
Labelling
V/MRP/21/0037-01
10
Stikla flakons, 1000 deva
-
V/MRP/21/0037-02
10
Stikla flakons, 2500 deva
-
V/MRP/21/0037-03
10
Stikla flakons, 5000 deva
-
Poulvac IB QX
-
V/MRP/13/0019
Zoetis Belgium S.A., Beļģija
QI01AD07
chickens
Vairāk
Medicinal product information
Pharmaceutical form:
lyophilisate for oculonasal suspension
International name (active substance):
Live attenuated Avian Infectious BronchitisVirus, Strain L1148
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Zoetis Manufacturing & Research Spain S.L., Spānija
Date of authorisation/renewal:
29-Dec-2015
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
MRP
Package leaflet:
[PDF] Skat_sadaļā_Zāļu_apraksts (17-Dec-2024)
Labelling text:
[PDF] Skat_sadaļā_Zāļu_apraksts (17-Dec-2024)
Summary of product characteristics:
[DOCX] Zāļu_informācija_ZA_M_LI (17-Dec-2024)
Products
ID
Strength
Package size
Primary packaging
Labelling
V/MRP/13/0019-01
10
Stikla flakons, 2000 deva
-
V/MRP/13/0019-02
10
Stikla flakons, 5000 deva
-
V/MRP/13/0019-03
10
Stikla flakons, 10000 deva
-
V/MRP/13/0019-04
1
Stikla flakons, 2000 deva
-
V/MRP/13/0019-05
1
Stikla flakons, 5000 deva
-
V/MRP/13/0019-06
1
Stikla flakons, 10000 deva
-
Poulvac NDW
-
V/MRP/14/0047
Zoetis Belgium S.A., Beļģija
QI01AD06
chickens
Vairāk
Medicinal product information
Products
ID
Strength
Package size
Primary packaging
Labelling
V/MRP/14/0047-01
10
Flakons, 2000 deva
-
V/MRP/14/0047-02
10
Flakons, 5000 deva
-
Karbaseptas
-
V/NRP/03/1571
RUVERA, UAB, Lietuva
QD02AX
cattle; horses; dogs; cats
Vairāk
Medicinal product information
Products
ID
Strength
Package size
Primary packaging
Labelling
V/NRP/03/1571-01
1
Polipropilēna trauciņš, 100 g
-
V/NRP/03/1571-04
1
Polipropilēna trauciņš, 250 g
-
V/NRP/03/1571-06
1
Polipropilēna spainis, 1 kg
-
V/NRP/03/1571-07
1
ABPE spainis/PE vāciņš, 10 kg
-
V/NRP/03/1571-08
1
PP spainis/PP vāciņš, 18 kg
-
V/NRP/03/1571-10
1
PP spainis/PP vāciņš, 10 kg
-
Rispoval IBR-Marker Inactivatum
-
V/MRP/08/1573
Zoetis Belgium S.A., Beļģija
QI02AA03
cattle
Vairāk
Medicinal product information
Products
ID
Strength
Package size
Primary packaging
Labelling
V/MRP/08/1573-02
1
Stikla flakons, 10 deva
-
V/MRP/08/1573-03
1
Stikla flakons, 50 deva
-
Thiamavance
10 mg/ml
V/DCP/25/0078
VIRBAC, Francija
QH03BB02
cats
Vairāk
Medicinal product information
Products
ID
Strength
Package size
Primary packaging
Labelling
V/DCP/25/0078-01
1
Stikla pudele (šļirce graduēta pa 0,5 mg iedaļām), 30 ml
-
V/DCP/25/0078-02
1
Stikla pudele (šļirce graduēta pa 1,25 mg iedaļām), 30 ml
-
Supprestral injectable
50 mg/ml
V/NRP/03/1579
Vetoquinol S.A., Francija
QG03AC06
dogs; cats
Vairāk
Medicinal product information
Pharmaceutical form:
solution for injection
International name (active substance):
Medroxyprogesterone acetate
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Vetoquinol S.A., Francija
Date of authorisation/renewal:
22-Sep-2008
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
NRP
Package leaflet:
[DOC] 267-220908LI (22-Sep-2008)
Labelling text:
[DOC] 220908M (22-Sep-2008)
Summary of product characteristics:
[DOC] 267-220908ZA (22-Sep-2008)
Products
ID
Strength
Package size
Primary packaging
Labelling
V/NRP/03/1579-01
50 mg/ml
1
Flakons, 5 ml
-
Covexin 10
-
V/MRP/10/0020
Zoetis Belgium S.A., Beļģija
QI04AB01;QI02AB01
cattle; sheep
Vairāk
Medicinal product information
Pharmaceutical form:
suspension for injection
International name (active substance):
Clostridium perfringens, epsilon-toxoid (type D), Clostridium perfringens, beta-toxoid (type B and C), Toxoid Clostridium novyi, Clostridium tetani toxoid, C. perfringens type A toxoid, C. chauvoei whole culture, C. septicum toxoid, C. sordellii toxoid, C. haemolyticum toxoid
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Pfizer Animal Health S.A., Beļģija
Date of authorisation/renewal:
31-Mar-2015
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
MRP
Package leaflet:
[PDF] Skat_sadaļā_Zāļu_apraksts (23-Nov-2023)
Labelling text:
[PDF] Skat_sadaļā_Zāļu_apraksts (23-Nov-2023)
Summary of product characteristics:
[DOCX] Zāļu_informācija_ZA_M_LI (23-Nov-2023)
Products
ID
Strength
Package size
Primary packaging
Labelling
V/MRP/10/0020-02
1
Polietilēna pudele, 50 ml
-
V/MRP/10/0020-03
1
Polietilēna pudele, 100 ml
-
Rispoval 3 BRSV Pi3 BVD
-
V/MRP/05/1643
Zoetis Belgium S.A., Beļģija
QI02AH
cattle
Vairāk
Medicinal product information
Pharmaceutical form:
lyophilisate and suspension for suspension for injection
International name (active substance):
Bovine Viral Diarrhoea Virus (BVD), strain 6309, killed,Bovine Parainfluenza 3 virus (Pi3) RLB 103 attennuated,Inactivated Bovine Viral Diarrhoea virus, cytopathic strain 5960,Bovine respiratory syncytial virus
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Zoetis Animal Health SA, Beļģija
Date of authorisation/renewal:
31-Mar-2010
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
MRP
Package leaflet:
[PDF] Skat_sadaļā_Zāļu_apraksts (26-Mar-2024)
Labelling text:
[PDF] Skat_sadaļā_Zāļu_apraksts (26-Mar-2024)
Summary of product characteristics:
[DOCX] Zāļu_informācija_ZA_M_LI (26-Mar-2024)
Products
ID
Strength
Package size
Primary packaging
Labelling
V/MRP/05/1643-01
1
Stikla flakons, 5 deva
-
V/MRP/05/1643-02
1
Stikla flakons, 25 deva
-
Kolibin RC NEO
-
V/NRP/18/0033
Bioveta, a.s., Čehija
QI02AL01
cattle
Vairāk
Medicinal product information
Pharmaceutical form:
emulsion for injection
International name (active substance):
Inactivated E.coli bacteria,Inactivated bovine coronavirus strain C-197,Inactivated Bovine rotavirus, strain TM-91
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Bioveta, a.s., Čehija
Date of authorisation/renewal:
28-Jan-2022
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
NRP
Package leaflet:
[PDF] Skat_sadaļā_Zāļu_apraksts (16-Feb-2026)
Labelling text:
[PDF] Skat_sadaļā_Zāļu_apraksts (16-Feb-2026)
Summary of product characteristics:
[DOCX] Zāļu_informācija_ZA_M_LI (16-Feb-2026)
Products
ID
Strength
Package size
Primary packaging
Labelling
V/NRP/18/0033-01
2
Stikla flakons, 1 deva
-
V/NRP/18/0033-02
10
Stikla flakons, 1 deva
-
V/NRP/18/0033-03
20
Stikla flakons, 1 deva
-
V/NRP/18/0033-04
1
Stikla flakons, 2 deva
-
V/NRP/18/0033-05
5
Stikla flakons, 2 deva
-
V/NRP/18/0033-06
10
Stikla flakons, 2 deva
-
V/NRP/18/0033-07
1
Stikla flakons, 5 deva
-
V/NRP/18/0033-08
1
Plastikāta flakons, 5 deva
-
V/NRP/18/0033-09
5
Stikla flakons, 5 deva
-
V/NRP/18/0033-10
5
Plastikāta flakons, 5 deva
-
V/NRP/18/0033-11
10
Stikla flakons, 5 deva
-
V/NRP/18/0033-12
10
Plastikāta flakons, 5 deva
-
V/NRP/18/0033-13
1
Stikla flakons, 10 deva
-
V/NRP/18/0033-14
5
Stikla flakons, 10 deva
-
V/NRP/18/0033-15
10
Stikla flakons, 10 deva
-
V/NRP/18/0033-16
1
Stikla flakons, 25 deva
-
V/NRP/18/0033-17
1
Plastikāta flakons, 25 deva
-
V/NRP/18/0033-18
12
Stikla flakons, 25 deva
-
V/NRP/18/0033-19
12
Plastikāta flakons, 25 deva
-
V/NRP/18/0033-20
24
Stikla flakons, 25 deva
-
V/NRP/18/0033-21
24
Plastikāta flakons, 25 deva
-
V/NRP/18/0033-22
1
Stikla flakons, 50 deva
-
V/NRP/18/0033-23
1
Plastikāta flakons, 50 deva
-
V/NRP/18/0033-24
12
Stikla flakons, 50 deva
-
V/NRP/18/0033-25
12
Plastikāta flakons, 50 deva
-
V/NRP/18/0033-26
20
Stikla flakons, 50 deva
-
V/NRP/18/0033-27
20
Plastikāta flakons, 50 deva
-
V/NRP/18/0033-28
1
Plastikāta flakons, 125 deva
-
V/NRP/18/0033-29
12
Plastikāta flakons, 125 deva
-
V/NRP/18/0033-30
20
Plastikāta flakons, 125 deva
-
PestiGon Combo 402 mg / 361,8 mg
-
V/DCP/17/0017
Norbrook Laboratories (Ireland) Limited, Īrija
QP53AX65
very large dogs
Vairāk
Medicinal product information
Pharmaceutical form:
spot-on solution
International name (active substance):
Fipronil,S-Methoprene
Distribution category:
Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release
Norbrook Laboratories Limited, Lielbritānija;Norbrook Manufacturing Limited, Īrija
Date of authorisation/renewal:
29-Mar-2022
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
DCP
Package leaflet:
[DOCX] 29032022LI (29-Mar-2022)
Labelling text:
[DOCX] 29032022M (29-Mar-2022)
Summary of product characteristics:
[DOCX] 29032022ZA (29-Mar-2022)
Products
ID
Strength
Package size
Primary packaging
Labelling
V/DCP/17/0017-01
1
Pipete, 1 deva
-
V/DCP/17/0017-02
2
Pipete, 1 deva
-
V/DCP/17/0017-03
3
Pipete, 1 deva
-
V/DCP/17/0017-04
4
Pipete, 1 deva
-
V/DCP/17/0017-05
6
Pipete, 1 deva
-
V/DCP/17/0017-06
8
Pipete, 1 deva
-
V/DCP/17/0017-07
12
Pipete, 1 deva
-
V/DCP/17/0017-08
24
Pipete, 1 deva
-
V/DCP/17/0017-09
30
Pipete, 1 deva
-
V/DCP/17/0017-10
60
Pipete, 1 deva
-
V/DCP/17/0017-11
90
Pipete, 1 deva
-
V/DCP/17/0017-12
120
Pipete, 1 deva
-
V/DCP/17/0017-13
150
Pipete, 1 deva
-
Noroclox DC
500 mg
V/NRP/96/0443
Norbrook Laboratories (Ireland) Limited, Īrija
QJ51CF02
cows
Vairāk
Medicinal product information
Products
ID
Strength
Package size
Primary packaging
Labelling
V/NRP/96/0443-01
500 mg
24
Injektors, 1 deva
-
V/NRP/96/0443-02
500 mg
120
Injektors, 1 deva
-
BioRabbit RHDV 1,2
-
V/DCP/23/0007
Bioveta, a.s., Čehija
QI08AA01
rabbits
Vairāk
Medicinal product information
Products
ID
Strength
Package size
Primary packaging
Labelling
V/DCP/23/0007-01
10
Stikla flakons (plastmasas kastē), 1 deva
-
V/DCP/23/0007-02
10
Stikla flakons (plastmasas kastē), 10 deva
-
V/DCP/23/0007-03
10
Stikla flakons (plastmasas kastē), 20 deva
-
V/DCP/23/0007-04
1
ABPE flakons (kartona kastē), 10 deva
-
V/DCP/23/0007-05
1
ABPE flakons (kartona kastē), 20 deva
-
V/DCP/23/0007-06
1
Stikla flakons (kartona kastē), 10 deva
-
V/DCP/23/0007-07
1
Stikla flakons (kartona kastē), 20 deva
-
V/DCP/23/0007-08
10
ABPE flakons (plastmasas kastē), 10 deva
-
V/DCP/23/0007-09
10
ABPE flakons (plastmasas kastē), 20 deva
-
Seton 2%
20 mg/ml
V/NRP/02/1422
Laboratorios Calier, S.A., Spānija
QN05CM92
cattle; horses; dogs; cats
Vairāk
Medicinal product information
Pharmaceutical form:
solution for injection
International name (active substance):
Xylazine hydrochloride
Distribution category:
To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release
Laboratorios Calier, S.A., Spānija
Date of authorisation/renewal:
21-May-2008
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
NRP
Package leaflet:
[PDF] 211116LI (02-Dec-2016)
Labelling text:
[PDF] 211116M (02-Dec-2016)
Summary of product characteristics:
[PDF] 211116ZA (02-Dec-2016)
Products
ID
Strength
Package size
Primary packaging
Labelling
V/NRP/02/1422-01
1
Flakons, 25 ml
-
V/NRP/02/1422-02
1
Flakons, 10 ml
-
Cevac MD HVT
-
V/DCP/16/0037
Ceva-Phylaxia Co.Ltd., Ungārija
QI01AD03
chickens
Vairāk
Medicinal product information
Pharmaceutical form:
suspension and diluent for suspension for injection
International name (active substance):
Live Turkey Herpes virus
Distribution category:
To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release
Ceva-Phylaxia Veterinary Biologicals Co. Ltd., Ungārija
Date of authorisation/renewal:
29-Nov-2021
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
DCP
Package leaflet:
[DOCX] 26112021LI (26-Nov-2021)
Labelling text:
[DOCX] 26112021M (26-Nov-2021)
Summary of product characteristics:
[DOCX] 26112021ZA (26-Nov-2021)
Products
ID
Strength
Package size
Primary packaging
Labelling
V/DCP/16/0037-01
1
Ampula, 500 deva
-
V/DCP/16/0037-02
1
Ampula, 1000 deva
-
V/DCP/16/0037-03
1
Ampula, 2000 deva
-
V/DCP/16/0037-04
1
Ampula, 4000 deva
-
V/DCP/16/0037-05
1
Maiss (šķīdinātājs), 200 ml
-
V/DCP/16/0037-06
1
Maiss (šķīdinātājs), 400 ml
-
V/DCP/16/0037-07
1
Maiss (šķīdinātājs), 800 ml
-
V/DCP/16/0037-08
1
Maiss (šķīdinātājs), 1000 ml
-
V/DCP/16/0037-09
1
Maiss (šķīdinātājs), 1200 ml
-
V/DCP/16/0037-10
1
Maiss (šķīdinātājs), 1600 ml
-
Ingelvac Ery emulsija injekcijām cūkām
-
V/DCP/21/0030
Boehringer Ingelheim Vetmedica GmbH, Vācija
QI09AB03
pigs
Vairāk
Medicinal product information
Pharmaceutical form:
emulsion for injection
International name (active substance):
Erysipelothrix rhusiopathiae, serotype 2, strain SE-9, Inactivated
Distribution category:
To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release
LABORATORIOS SYVA, S.A.U. , Spānija
Date of authorisation/renewal:
28-Jan-2022
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
DCP
Package leaflet:
[DOCX] 08042024_LI (08-Apr-2024)
Labelling text:
[DOCX] 19122022_M (19-Dec-2022)
Summary of product characteristics:
[DOCX] 19122022_ZA (19-Dec-2022)
Products
ID
Strength
Package size
Primary packaging
Labelling
V/DCP/21/0030-01
1
Polipropilēna flakons, 100 ml
-
Thyrovet
800 µg
V/DCP/24/0008
CP-Pharma Handelsgesellschaft GmbH, Vācija
QH03AA01
dogs; cats
Vairāk
Medicinal product information
Products
ID
Strength
Package size
Primary packaging
Labelling
V/DCP/24/0008-01
800 µg/tabl.
3
AL/PVC-AL-PA blisteris, 10 tablete
-
V/DCP/24/0008-02
800 µg/tabl.
10
AL/PVC-AL-PA blisteris, 10 tablete
-